Logo image of PRAX

PRAXIS PRECISION MEDICINES I (PRAX) Stock Earnings & Estimates

NASDAQ:PRAX - US74006W2070 - Common Stock

44.94 USD
-0.6 (-1.32%)
Last: 9/2/2025, 8:26:57 PM
44.94 USD
0 (0%)
After Hours: 9/2/2025, 8:26:57 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
PRAX revenue by date.PRAX revenue by date.
2.447M8.553M
249.53%
112.2K
-98.69%
140.25K
25.00%
66.9M
47,600.53%
158.36M
136.71%
441.99M
179.10%
872.62M
97.43%
1.284B
47.14%
1.716B
33.64%
EBITDA
YoY % growth
PRAX ebitda by date.PRAX ebitda by date.
-213.57M
-27.77%
-125.941M
41.03%
-199.807M
-58.65%
-299.111M
-49.70%
-273.171M
8.67%
-278.878M
-2.09%
-266.242M
4.53%
-204.443M
23.21%
-144.904M
29.12%
-51.043M
64.77%
40.121M
178.60%
EBIT
YoY % growth
PRAX ebit by date.PRAX ebit by date.
-213.99M
-27.89%
-126.373M
40.94%
-200.165M
-58.39%
-305.541M
-52.64%
-293.189M
4.04%
-280.684M
4.27%
-189.11M
32.63%
43.433M
122.97%
464.83M
970.22%
845.79M
81.96%
1.279B
51.22%
Operating Margin
PRAX operating margin by date.PRAX operating margin by date.
N/A-5,164.41%-2,340.29%-272,317.94%-209,047.27%-419.56%-119.42%9.83%53.27%65.87%74.53%
EPS
YoY % growth
PRAX eps by date.PRAX eps by date.
-16.84
-332.90%
-23.67
-40.56%
-10.27
56.61%
-13.61
-32.49%
-12.42
8.73%
-10.55
15.04%
-7.10
32.74%
1.77
124.92%
16.63
840.36%
25.91
55.78%
34.49
33.12%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-3.44
-24.96%
-3.44
-17.01%
-3.42
-3.91%
-3.42
-3.28%
-3.39
1.31%
-3.25
5.42%
Revenue
Q2Q % growth
51K
-83.11%
61.2K
-99.18%

-100.00%

-100.00%
EBITDA
Q2Q % growth
-74.404M
-31.63%
-70.992M
-11.63%
-66.606M
10.81%
-67.881M
10.65%
-69.136M
7.08%
-70.38M
0.86%
EBIT
Q2Q % growth
-76.34M
-34.32%
-76.736M
-19.98%
-80.262M
-7.40%
-79.511M
-4.53%
-78.957M
-3.43%
-78.307M
-2.05%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-3.31
-90.23%
-3.400.092.57%
Q1 2025
Q2Q % growth
-3.29
-15.85%
-3.27-0.02-0.77%
Q4 2024
Q2Q % growth
-2.94
1.01%
-2.90-0.04-1.25%
Q3 2024
Q2Q % growth
-2.75
-1.85%
-2.03-0.72-35.55%
Q2 2024
Q2Q % growth
-1.74
76.33%
-2.360.6226.31%
Q1 2024
Q2Q % growth
-2.84
73.33%
-2.12-0.72-33.68%
Q4 2023
Q2Q % growth
-2.97
77.24%
-3.250.288.58%
Q3 2023
Q2Q % growth
-2.70
-181.25%
-5.362.6649.58%
Q2 2023
Q2Q % growth
-7.35
-456.82%
-10.032.6826.70%
Q1 2023
Q2Q % growth
-10.65
-605.30%
-12.021.3711.41%
Q4 2022
Q2Q % growth
-13.05
-903.85%
-12.01-1.04-8.65%
Q3 2022
Q2Q % growth
-0.96
4.00%
-0.90-0.06-6.23%
Q2 2022
Q2Q % growth
-1.32
-50.00%
-1.320.000.32%
Q1 2022
Q2Q % growth
-1.51
-112.68%
-1.33-0.18-13.44%
Q4 2021
Q2Q % growth
-1.30
-49.43%
-1.10-0.20-17.83%
Q3 2021
Q2Q % growth
-1.00
91.74%
-0.95-0.05-4.97%
Q2 2021
Q2Q % growth
-0.88 -0.69-0.19-27.81%
Q1 2021
Q2Q % growth
-0.71 -0.760.056.25%
Q4 2020
Q2Q % growth
-0.87 -0.38-0.49-127.45%
Q3 2020
Q2Q % growth
-12.10 -0.74-11.36-1,525.03%
PRAX Yearly EPS VS EstimatesPRAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 20 -20 -40 -60
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth

-100.00%
148.369K-148.369K-100.00%
Q1 2025
Q2Q % growth

-100.00%
142.8K-142.8K-100.00%
Q4 2024
Q2Q % growth
7.463M
1,349.13%
366.272K7.097M1,937.56%
Q3 2024
Q2Q % growth
302K
-35.47%
301.92K800.03%
Q2 2024
Q2Q % growth
357K
-54.29%
849.66K-492.66K-57.98%
Q1 2024
Q2Q % growth
431K
-36.90%
1.654M-1.223M-73.94%
Q4 2023
Q2Q % growth
515K 51K464K909.80%
PRAX Yearly Revenue VS EstimatesPRAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.52% -12.18% -2.79% -3.72%
Revenue-63.33% -80.85% -74.26% N/A